European randomized controlled trial evaluating differential target multiplexed spinal cord stimulation and conventional medical management in subjects with persistent back pain ineligible for spine surgery: 24‐month results
European Journal of Pain · 2024-11 · 28 (10) · 1745-1761
DOI: 10.1002/ejp.2306 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Pain, online erschienen am 28.06.2024. Verfasst von Jan W Kallewaard und 14 weiteren Autor:innen. Beteiligte Einrichtung: Rijnstate, Elst, The Netherlands. Hauptthemen laut MEDLINE: Spinal Cord Stimulation, Low Back Pain. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Differential target multiplexed spinal cord stimulation (DTM SCS) was shown to be superior to conventional SCS for treating chronic low back pain (CLBP) in subjects with persistent spinal pain syndrome with previous spinal surgery (PSPS‐T2) or ineligible for it (PSPS‐T1). This study reports 24‐month efficacy and safety of DTM SCS vs. conventional medical management (CMM) in PSPS‐T1 subjects across four European countries.
Methods
This is a prospective, multicenter, open‐label, randomized, controlled trial with optional crossover. Subjects randomized 1:1 to DTM SCS or CMM. Primary endpoint was responder rate (% subjects reporting ≥50% CLBP relief) at 6 months. A superiority test compared responder rates between treatments. CLBP and leg pain levels, functional disability, quality of life (QoL), patient satisfaction and global impression of change were evaluated for 24 months. A Composite Responder Index (CRI) was obtained using CLBP relief, disability and QoL. Incidence of study‐related adverse events evaluated safety.
Results
A total of 55 and 57 subjects were randomized to DTM SCS and CMM respectively. DTM SCS was superior, with CLBP responder rates ≥80% and CLBP relief >5.6 cm (>70% reduction) through the 24‐month follow‐up. Improvements with DTM SCS in other outcomes were sustained. The CRI was >80% for DTM SCS through 24 months. Opioid medication intake decreased in subjects treated with DTM SCS. Most patients treated with DTM SCS felt satisfied and improved at the end of the study. Safety was congruent with other studies.
Conclusion
DTM SCS is efficacious and safe during 24 months for the treatment of CLBP and leg pain in PSPS‐T1 patients ineligible for spine surgery. Significance statement This randomized controlled trial shows that Differential Target Multiplexed SCS (DTM SCS) is an effective and safe long‐term treatment for PSPS type 1 patients suffering from axial low back pain with or without leg pain and who are ineligible for spinal surgery. Currently, CMM treatments are their only option and provide limited benefits. Besides superior pain relief, DTM SCS provides significant improvements in functional disability, quality of life, high levels of satisfaction and perceived impression of change.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Rijnstate, Elst, The Netherlands.
- Amsterdam University Medical Centre, Amsterdam, The Netherlands.
- AZ Delta, Roeselare, Belgium.
- GZA Hospitals, Wilrijk, Belgium.
- Vitaz, St Niklaas, Belgium.
- Hospital Universitario Puerta de Hierro, Madrid, Spain.
Zitieren
APA
Kallewaard, J. W., Billet, B., Van Paesschen, R., Smet, I., Mendiola, A., Peña, I., López, P., Carceller, J., Tornero, C., Zuidema, X., Vesper, J., Lehmberg, J., Laloo, W., Cedeño, D. L., & Vallejo, R. (2024). European randomized controlled trial evaluating differential target multiplexed spinal cord stimulation and conventional medical management in subjects with persistent back pain ineligible for spine surgery: 24‐month results. European Journal of Pain, 28(10), 1745-1761. https://doi.org/10.1002/ejp.2306
Vancouver
Kallewaard JW, Billet B, Van Paesschen R, Smet I, Mendiola A, Peña I, et al. European randomized controlled trial evaluating differential target multiplexed spinal cord stimulation and conventional medical management in subjects with persistent back pain ineligible for spine surgery: 24‐month results. European Journal of Pain. 2024;28(10):1745-1761. doi:10.1002/ejp.2306
BibTeX
@article{Kallewaard2024,
author = {Kallewaard, Jan W and Billet, Bart and Van Paesschen, Raf and Smet, Iris and Mendiola, Agustin and Peña, Isaac and López, Pablo and Carceller, Javier and Tornero, Carlos and Zuidema, Xander and Vesper, Jan and Lehmberg, Jens and Laloo, Wim and Cedeño, David L and Vallejo, Ricardo},
title = {European randomized controlled trial evaluating differential target multiplexed spinal cord stimulation and conventional medical management in subjects with persistent back pain ineligible for spine surgery: 24‐month results},
journal = {European Journal of Pain},
year = {2024},
volume = {28},
number = {10},
pages = {1745--1761},
doi = {10.1002/ejp.2306}
}
EUVIMED